Companies / Institutes

Epimune GmbH

Rudower Chaussee 29, 12489 Berlin

+49 30 6392-3499
+49 30 6392-3490

Focus

Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood.

News

Epimune GmbH and Tanner Pharma Group enter into Distribution Partnership for Latin America
Approvals of in-vitro diagnostic tests for immune cell quantification are expected within the second half of 2021
Epimune
Robust Immune Diagnostics
The young company Epimune GmbH is detecting immune diseases with epigenetic methods